REAX Jumps 26% as EPS Growth Estimate Nearly Doubles
Real REMAX Group (REAX) surged 26.0% to $17.14 after its forward EPS growth estimate was revised from 195.2% to 294.2% on October 14. Black Rock Coffee Bar (BRCB) gained 19.4% following a modest 1.3pp upward revision to 30.0%, while Appian (APPN) rose 15.0% on analyst optimism and an upcoming earnings date. The screen caught these revisions early, and price action has since confirmed the improving fundamentals.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| REAX | Real Estate | 2026-10-14 | +99.0pp | +26.0% |
| BRCB | Consumer Cyclical | 2026-10-14 | +1.3pp | +19.4% |
| APPN | Technology | 2026-10-13 | N/A | +15.0% |
| AGIO | Healthcare | 2026-10-15 | N/A | +13.4% |
| CSGP | Real Estate | 2026-10-12 | N/A | +13.2% |
Why did REAX stock jump in October 2026?
REAX jumped 26.0% (from $13.60 to $17.14) after analysts raised its forward EPS growth estimate from 195.2% to 294.2% on October 14.
The dramatic 99-percentage-point upward revision signaled a major earnings inflection for the real estate firm, catching the screener's attention at $13.60. On October 19, the company announced it will host its third-quarter 2026 earnings conference call, reinforcing expectations for strong results. The combination of a near-tripling of expected EPS growth and an imminent earnings catalyst drove the stock to its current level.
REAX EPS revision history → · Screener snapshot from 2026-10-14 →
FAQ: REAX
Why did REAX stock jump 26%?
REAX jumped 26.0% (from $13.60 to $17.14) after analysts raised its forward EPS growth estimate from 195.2% to 294.2% on October 14, 2026.
What is REAX's EPS growth estimate?
REAX's next-year EPS growth estimate was revised upward to 294.2% on October 14, 2026, up from 195.2% previously.
Is REAX a buy after the rally?
The sharp upward EPS revision and upcoming Q3 earnings call suggest strong momentum, but the stock has already gained 26% since detection, so investors should assess valuation carefully.
Why did BRCB stock jump in October 2026?
BRCB gained 19.4% (from $7.22 to $8.62) after its forward EPS growth estimate was revised upward to 30.0% from 28.7% on October 14.
The 1.3-percentage-point revision, while small, was enough to trigger the screener as it signaled improving profitability for the coffee bar chain. No specific earnings-related news was found, but the price action suggests the market is confirming the positive earnings outlook. The gain reflects growing confidence in the company's ability to deliver consistent growth.
BRCB EPS revision history → · Screener snapshot from 2026-10-14 →
FAQ: BRCB
Why did BRCB stock rise 19.4%?
BRCB rose 19.4% (from $7.22 to $8.62) after its forward EPS growth estimate was revised upward to 30.0% from 28.7% on October 14, 2026.
What is BRCB's EPS growth estimate?
BRCB's next-year EPS growth estimate is 30.0% following a 1.3-percentage-point upward revision on October 14, 2026.
Is BRCB a buy after the rally?
The upward EPS revision and 19.4% price gain indicate positive momentum, but with limited news, investors may want to monitor upcoming earnings for confirmation.
Why did APPN stock jump in October 2026?
APPN jumped 15.0% (from $38.71 to $44.51) after Citi highlighted AI upside on October 15 and the company set its Q3 earnings date for November 5.
The stock's 31.3% next-year EPS growth estimate caught the screener on October 13, and Citi's bullish call reinforced the outlook, citing accelerating cloud growth and improving federal demand. The upcoming earnings report gives investors a near-term catalyst to validate the AI-driven growth narrative. The rally reflects both the fundamental revision and analyst endorsement.
APPN EPS revision history → · Screener snapshot from 2026-10-13 →
FAQ: APPN
Why did APPN stock jump 15%?
APPN jumped 15.0% (from $38.71 to $44.51) after Citi highlighted AI upside on October 15, 2026, and the company announced its Q3 earnings date for November 5.
What is APPN's EPS growth estimate?
APPN's next-year EPS growth estimate is 31.3%, which caught the screener on October 13, 2026.
Is APPN a buy after the rally?
Citi maintains a buy rating, citing stronger execution and AI demand, but the stock has already gained 15% since detection, so valuation should be considered.
Why did AGIO stock jump in October 2026?
AGIO climbed 13.4% (from $32.32 to $36.64) after its next-year EPS growth estimate of 34.9% was flagged by the screener on October 15.
The healthcare company has no specific earnings-related news in the window, but the strong growth projection alone attracted buyers. The rally suggests the market is pricing in improved profitability for Agios, likely driven by its rare disease portfolio. The move reflects broader sector momentum and confidence in the company's pipeline.
AGIO EPS revision history → · Screener snapshot from 2026-10-15 →
FAQ: AGIO
Why did AGIO stock rise 13.4%?
AGIO rose 13.4% (from $32.32 to $36.64) after the screener detected its 34.9% next-year EPS growth estimate on October 15, 2026.
What is AGIO's EPS growth estimate?
AGIO's next-year EPS growth estimate is 34.9%, which triggered the EPS revision screener on October 15, 2026.
Is AGIO a buy after the rally?
The 34.9% EPS growth estimate and 13.4% price gain suggest positive momentum, but without specific news, investors should watch for upcoming catalysts.
Why did CSGP stock jump in October 2026?
CSGP rose 13.2% (from $29.21 to $33.05) after its 26.2% next-year EPS growth estimate was detected by the screener on October 12.
On October 20, CoStar's BizBuySell released its Q3 2026 Insight Report, showing stable transaction activity with a 17% increase in median sale price, reinforcing the company's market position. The report highlighted strong demand for high-quality businesses despite softer buyer and seller confidence, supporting CSGP's growth outlook. The combination of a solid EPS estimate and positive subsidiary data drove the stock higher.
CSGP EPS revision history → · Screener snapshot from 2026-10-12 →
FAQ: CSGP
Why did CSGP stock gain 13.2%?
CSGP gained 13.2% (from $29.21 to $33.05) after its 26.2% next-year EPS growth estimate was detected on October 12, 2026, and BizBuySell's Q3 report showed a 17% rise in median sale price.
What is CSGP's EPS growth estimate?
CSGP's next-year EPS growth estimate is 26.2%, which triggered the screener on October 12, 2026.
Is CSGP a buy after the rally?
The 26.2% EPS growth estimate and BizBuySell's stable transaction data support the growth story, but the stock has already risen 13.2%, so investors should evaluate entry points.
Today's top performers—led by REAX's 26% surge on a near-doubling of EPS growth expectations—show that markets are rewarding companies with strong earnings revisions, especially when accompanied by upcoming catalysts. The broad gains across real estate, consumer, tech, and healthcare suggest improving sentiment toward growth-oriented stocks with upward estimate momentum.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →